sever
acut
respiratori
syndrom
sar
sever
infecti
diseas
affect
mani
countri
region
sinc
novel
member
coronaviru
sarscov
identifi
caus
agent
howev
pathogenesi
sar
still
elus
studi
use
dige
ms
analyz
protein
profil
plasma
sar
patient
search
proteom
alter
associ
diseas
progress
could
provid
clue
pathogenesi
enrich
lowabund
protein
human
plasma
two
highli
abund
protein
albumin
igg
first
remov
compar
plasma
protein
sar
patient
normal
control
group
sever
protein
signific
alter
found
upregul
protein
identifi
acid
glycoprotein
haptoglobin
antichymotrypsin
fetuin
downregul
protein
apolipoprotein
ai
transferrin
transthyretin
protein
show
signific
chang
upor
downregul
progress
phase
diseas
trend
back
normal
level
convalesc
phase
among
protein
alter
fetuin
antichymotrypsin
confirm
western
blot
sinc
upregul
protein
identifi
wellknown
inflamm
inhibitor
result
strongli
suggest
bodi
start
inflamm
inhibit
sustain
inflammatori
respons
balanc
progress
sar
abbrevi
act
antichymotrypsin
agp
acid
glycoprotein
app
acutephas
protein
hp
haptoglobin
sar
sever
acut
respiratori
syndrom
sarscov
sar
coronaviru
author
contribut
equal
work
novemb
sever
diseas
call
sever
acut
respiratori
syndrom
sar
found
southern
china
spread
worldwid
sever
month
probabl
sar
case
death
report
countri
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
separ
identifi
pathogen
sar
serolog
rtpcr
method
subsequ
mani
effort
made
studi
mechan
infect
structur
viru
howev
studi
patholog
chang
vivo
affect
patient
plasma
wide
use
clinic
resourc
close
correl
diseas
progress
analysi
profil
plasma
protein
alter
promis
way
tri
elucid
pathogenesi
sar
develop
proteom
mani
technolog
employ
studi
plasma
proteom
compar
proteom
accur
quantit
good
reproduc
basi
provid
reliabl
data
dige
fluorescencebas
techniqu
protein
visual
quantif
could
compens
shortag
convent
silver
cbb
stain
data
protein
label
prior
electrophoresi
fluoresc
cydy
differ
label
sampl
cosepar
gel
studi
use
dige
compar
plasma
protein
profil
among
differ
sar
phase
onset
symptom
found
protein
show
interest
chang
progress
phase
might
correspond
patholog
state
sar
patient
lyophil
sampl
mg
dissolv
lysi
buffer
spot
interest
pick
spotcutt
biorad
accord
analysi
use
decyd
softwar
pick
gel
spot
destain
mm
gel
plug
lyophil
immers
ml
ngml
trypsin
solut
mm
nh
hco
digest
solut
kept
h
tryptic
peptid
mixtur
first
extract
ml
tfa
volum
acn
extract
solut
lyophil
use
identif
ms
peptid
extract
dissolv
ml
matrix
solut
mgml
hcca
tfa
acn
ml
solut
separ
spot
onto
appli
bioscienc
usa
target
plate
maldimsm
analysi
ms
mode
gener
ion
acceler
sourc
kv
separ
first
tof
tube
msm
mode
parent
ion
focus
ga
cell
fragment
use
cid
fragment
reacceler
kv
mz
valu
determin
second
tof
tube
mass
spectral
data
submit
search
swissprot
databas
gp
explor
softwar
base
mascot
search
engin
matrix
scienc
uk
protein
identif
probabl
given
mascot
consid
success
identifi
peptid
whose
ion
score
greater
list
could
give
good
match
fragment
ion
mass
spectrograph
sampl
run
sdspolyacrylamid
gel
transfer
onto
pvdf
membran
transblot
electrophoresi
transfer
cell
biorad
membran
block
overnight
mm
trishcl
mm
nacl
ph
tbst
contain
skim
milk
primari
antibodi
use
antifetuin
polyclon
antibodi
dilut
rockland
usa
antichymotrypsin
act
dilut
neomark
ca
usa
membran
incub
room
temperatur
h
primari
antibodi
wash
three
time
tbst
incub
horseradish
peroxidaseconjug
secondari
antibodi
dilut
santa
cruz
biotechnolog
ca
usa
h
room
temperatur
visual
immunoreact
protein
accomplish
use
ecl
reagent
santa
cruz
biotechnolog
membran
expos
xray
film
scan
scanner
biorad
semiquantit
analysi
base
od
perform
quantition
softwar
biorad
anova
test
analysi
accord
report
typic
clinic
cours
sar
definit
sar
sampl
divid
two
group
base
number
day
symptom
onset
state
ill
chest
radiograph
diagnosi
tabl
albumin
igg
account
protein
human
plasma
bar
analysi
remov
highabund
protein
serum
sampl
increas
visibl
lowabund
protein
enabl
precis
analysi
select
remov
highabund
protein
dige
effect
deplet
evalu
sdspage
good
effici
shown
fig
studi
alter
plasma
protein
sar
patient
compar
proteom
analysi
perform
among
normal
progress
phase
convalesc
phase
group
imag
sampl
three
group
label
differ
cyanin
dye
obtain
fluoresc
scan
fig
dige
imag
analyz
decyd
softwar
object
estim
abund
protein
sampl
gener
quantit
data
set
proper
filter
threshold
softwar
protein
spot
autodetect
base
threshold
ratio
softwar
detect
protein
spot
interest
show
signific
chang
among
three
group
compar
normal
plasma
protein
spot
upregul
downregul
progress
group
protein
spot
upregul
downregul
convalesc
group
rel
abund
volum
ratio
protein
spot
group
shown
fig
tabl
scan
gel
stain
syprorubi
match
dige
imag
softwar
protein
spot
signific
chang
pick
use
spotcutt
subject
ingel
digest
malditoftof
ms
analysi
cyanin
dye
sensit
syprorubi
stain
spot
dige
imag
invis
rubi
imag
spot
blindpick
refer
match
imag
spot
usual
fail
identifi
due
low
abund
identifi
protein
shown
tabl
unexpectedli
protein
shown
play
role
inflamm
control
infect
chang
identifi
protein
differ
group
summar
three
mode
fig
acid
glycoprotein
agp
act
fetuin
haptoglobin
hp
chain
upregul
group
progress
diseas
compar
normal
group
level
tend
return
normal
level
convalesc
group
b
hp
beta
chain
sustain
high
level
progress
convalesc
phase
c
apolipoprotein
transthyretin
transferrin
downregul
progress
group
rose
back
normal
level
convalesc
group
interest
protein
show
larger
alter
progress
phase
tend
return
normal
level
convalesc
phase
result
strongli
suggest
function
alter
protein
close
relat
diseas
progress
variant
identifi
protein
appear
differ
posit
gel
due
modif
variant
one
protein
show
similar
chang
gel
howev
variant
agp
transthyretin
hp
follow
pattern
differ
volum
ratio
fig
eg
spot
agp
differ
pi
gel
compar
normal
group
volum
ratio
spot
progress
group
volum
ratio
spot
suggest
variant
might
play
differ
role
sar
progress
valid
result
dige
use
western
blot
confirm
pool
sampl
individu
sampl
load
quantiti
detect
level
target
protein
gener
fetuin
neg
acut
reaction
protein
downregul
infect
howev
experi
show
contradictori
result
act
play
import
role
physiolog
lung
although
act
consid
acutephas
protein
app
report
upregul
plasma
sar
therefor
investig
two
protein
fetuin
act
use
western
blot
western
blot
film
scan
od
band
film
evalu
quantition
softwar
fig
result
valid
signific
upregul
fetuin
act
progress
phase
although
differ
progress
convalesc
group
statist
signific
trend
decreas
convalesc
sar
viral
pneumonia
progress
rapidli
pathogenesi
still
poorli
understood
studi
use
compar
proteom
technolog
dige
demonstr
characterist
alter
plasma
protein
progress
convalesc
phase
sar
alter
strongli
suggest
antiinflammatori
mechan
diseas
process
like
acut
respiratori
viral
infect
sarscov
induc
activ
immun
system
activ
often
excess
lung
caus
bystand
tissu
damag
airway
occlus
fine
balanc
immun
system
import
abil
clear
viru
damag
delic
architectur
lung
studi
report
inflammatori
patholog
sar
includ
cytokin
dysregul
immunopatholog
damag
studi
found
sever
plasma
protein
chang
significantli
progress
phase
sar
upregul
protein
agp
act
glycoprotein
fetuin
hp
downregul
protein
transferrin
transthyretin
apolipoprotein
ai
chang
protein
consequ
regress
convalesc
phase
alter
protein
app
known
take
part
inflamm
control
implic
activ
innat
immun
respons
infect
sarscov
suggest
inflammatori
respons
may
play
import
role
diseas
process
usual
viru
load
fall
day
onset
symptom
statu
patient
sar
still
deterior
suggest
excess
immunolog
respons
upregul
express
present
antiinflammatori
protein
progress
phase
could
play
protect
role
excess
inflammatori
respons
sustain
defens
homeostasi
sar
progress
improv
illustr
biolog
physic
function
protein
detail
act
serin
proteinas
inhibitor
serpin
target
enzym
cathepsin
g
mast
cell
chymas
chymotrypsin
acut
inflamm
equilibrium
blood
tissu
proteas
inhibitor
dramat
disturb
massiv
releas
proteas
injur
cell
infiltr
neutrophil
macrophag
occur
local
result
oxid
respiratori
burst
act
inhibit
action
proteolyt
pathway
form
stabl
complex
proteas
maintain
structur
integr
lower
respiratori
tract
act
also
thought
act
antiinflammatori
agent
inhibit
neutrophil
chemotaxi
superoxid
product
moreov
actcathepsin
g
complex
modul
secret
lung
fibroblast
creat
posit
feedback
control
acut
phase
reaction
studi
upregul
express
act
observ
impli
import
role
inflamm
control
also
call
human
fetuin
belong
cystatin
superfamili
proteas
inhibitor
involv
import
function
inhibit
insulin
receptor
tyrosin
kinas
activ
regul
calcium
metabol
osteogenesi
human
fetuin
demonstr
neg
app
man
circul
level
adult
fall
significantli
injuri
infect
howev
found
upregul
sar
patient
also
report
chen
et
al
could
explain
role
immunomodul
fetuin
influenc
resolut
inflamm
enhanc
phagocytosi
apoptot
cell
macrophag
antagon
deleteri
accumul
lung
may
caus
tissu
fibrosi
autoimmun
fetuin
also
opson
cation
macrophagedeactiv
molecul
suppress
releas
tumor
necrosi
factor
tnf
stimul
macrophag
control
magnitud
inflammatori
respons
suggest
posit
role
recoveri
phase
acut
inflammatori
respons
agp
play
import
biolog
function
variou
immunomodul
effect
agp
inhibit
activ
chemotaxi
oxid
metabol
polymorphonuclear
neutrophil
modul
cytokin
secret
monocytesmacrophag
moreov
agp
shown
protect
tnfainduc
cell
kill
complementinduc
lung
injuri
display
potent
platelet
aggreg
inhibitori
activ
vivo
function
potenti
import
pulmonari
inflammatori
respons
hp
sustain
high
level
express
progress
convalesc
phase
bestknown
biolog
function
hp
captur
hemoglobin
prevent
iron
loss
kidney
damag
hemolysi
sar
patient
high
oxid
stress
caus
activ
neutrophil
lung
plasma
hp
thought
major
antioxid
protect
agent
hemoglobindriven
free
radic
accumul
caus
membran
lipid
peroxid
vascular
endotheli
cell
damag
neutrophil
respiratori
burst
activ
inhibit
hp
moreov
hp
identifi
one
serum
angiogen
factor
angiogenesi
import
lung
tissu
repair
promot
growth
collater
vessel
could
anoth
reason
sustain
high
level
hp
convalesc
three
downregul
protein
transthyretin
transferrin
apolipoprotein
belong
neg
app
play
major
role
transport
nutrient
hormon
metabolit
clear
concentr
decreas
sar
plasma
although
past
believ
lower
concentr
neg
app
induc
stress
state
due
reduc
rate
synthesi
protein
studi
shown
concentr
neg
app
decreas
respons
infect
inflamm
increas
transcapillari
escap
rate
catabol
rate
balanc
rate
synthesi
catabol
loss
determin
circul
level
plasma
protein
studi
also
show
variant
hp
agp
transthyretin
gel
differ
volum
ratio
group
phenomenon
suggest
protein
differ
ptm
took
part
differ
pathway
diseas
process
final
caus
differ
chang
level
variant
blood
circul
exampl
put
role
variant
agp
alter
carbohydr
composit
immunomodul
protein
differ
ptm
might
specif
associ
sarscov
infect
addit
investig
need
reveal
natur
variant
signific
sar
hp
character
molecular
heterogen
three
major
phenotyp
consist
two
differ
polypeptid
chain
name
alpha
beta
sequenc
differ
hp
allel
result
amino
acid
sequenc
differ
correspond
protein
within
alpha
chain
wherea
beta
chain
sequenc
ident
allel
differ
spot
alpha
chain
visibl
gel
assign
genet
hp
subtyp
experi
pool
sampl
group
sever
patient
unknown
hp
phenotyp
inconsist
volum
ratio
hp
chain
may
due
differ
phenotyp
composit
group
conclus
shown
quantit
plasma
protein
profil
sar
patient
found
sever
protein
chang
significantli
diseas
progress
upregul
protein
rel
high
abund
plasma
play
posit
antiinflammatori
role
result
show
mechan
sustain
inflamm
balanc
sar
patient
help
proper
treatment
therapi
diseas
